Background The recent development of 20- and 19-gauge diameter endoscopes a
llows an excellent direct intravitreal visualization of intraocular morphol
ogy. A gradient index (GRIN) endoscope (Insight Instruments, Lake Mary, FL,
USA), which combines a small diameter (0.89 mm, 20 gauge) and an exception
al optical resolution, can be used as a diagnostic tool for the assessment
of the safety and vitreous interaction of sustained release intraocular dev
ices which have been designed to deliver ganciclovir (Vitrasert(R)) over a
period of 8-12 months and were successively implanted in several eyes.
Patients and Methods 78 eyes of 49 patients received 100 ganciclovir implan
ts between November 1995 and July 1998. In six patients who received additi
onal implants, the GRIN endoscope was used as an optical control of wound h
ealing processes and Vitrasert(R) positioning after implantation of prior d
evices (two-point suturing technique).
Results In all of these six eyes, a clinical stabilization of the cytomegal
ovirus retinitis was noted. Endoscopic observation of the scleral 5-mm inci
sion revealed no gaps after two-point suturing of the device. Only one of s
ix eyes showed significant vitreous tractions around the Vitrasert(R). Howe
ver, the struts of all pellets were completely covered by a fibrous membran
e. Occasional fibrous plaques were noted on the surface of devices which pr
esumably had been damaged by surgical manipulations. In one case, the endos
copic examination disclosed the suprachoroidal implantation of a device. In
this eye, no signs of retinal toxicity or recurrence of CMV retinitis were
observed.
Conclusions High resolution endoscopy of the vitreous cavity appears to be
an effective method for the control of intraocular drug delivery devices. B
asically, the repeated implantation of intraocular ganciclovir implants can
be considered a safe method in the management of relapsing CMV retinitis.
However, the endoscopic observation of fibrous membranes covering the strut
s suggest that the explantation of an intraocular device has the potential
for various intraoperative complications (e.g. hemorrhages, traction, tears
, retinal detachment). Therefore, we would recommend the additional implant
ation of further implants rather than a replacement.